Khuyến nghị của AGO về liệu pháp phẫu thuật ung thư vú: Cập nhật 2022
Tóm tắt
Từ khóa
Tài liệu tham khảo
N Ditsch, 2022, AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer (EBC): Update 2022, Breast Care, 10.1159/000524879
U Veronesi, 2002, Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056/NEJMoa020989
B Fisher, 2002, Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation, N Engl J Med, 347, 567, 10.1056/NEJMoa020128
S Agarwal, 2014, Effect of breast conservation therapy vs. mastectomy on disease-specific survival for early-stage breast cancer, JAMA Surg, 149, 267, 10.1001/jamasurg.2013.3049
S Hofvind, 2015, Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics, Eur J Surg Oncol, 41, 1417, 10.1016/j.ejso.2015.07.002
M C van Maaren, 2016, 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study, Lancet Oncol, 17, 1158, 10.1016/S1470-2045(16)30067-5
J de Boniface, 2021, Survival After Breast Conservation vs. Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48986 Women, JAMA Surg, 156, 628, 10.1001/jamasurg.2021.1438
P Christiansen, 2018, Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG), Acta Oncol, 57, 19, 10.1080/0284186X.2017.1403042
C Athanasiou, 2022, Comparative effectiveness of different localization techniques for non-palpable breast cancer. A systematic review and network meta-analysis, Eur J Surg Oncol, 48, 53, 10.1016/j.ejso.2021.10.001
M Banys-Paluchowski, 2022, Intraoperative Ultrasound-Guided Excision of Non-Palpable and Palpable Breast Cancer: Systematic Review and Meta-Analysis, Ultraschall Med, 10.1055/a-1821-8559
J H Volders, 2017, Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT), Eur J Surg Oncol, 43, 649, 10.1016/j.ejso.2016.11.004
J Hoffmann, 2019, Ultrasound-Assisted Tumor Surgery in Breast Cancer – A Prospective, Randomized, Single-Center Study (MAC001), Ultraschall Med, 40, 326, 10.1055/a-0637-1725
K L Krishna, 2020, A comparative study of perioperative techniques to attain negative margins and spare healthy breast tissue in breast conserving surgery, Breast Dis, 39, 127, 10.3233/BD-200443
S A Narod, 2015, Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ, JAMA Oncol, 1, 888, 10.1001/jamaoncol.2015.2510
J Hoffmann, 2009, Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients, BMC Cancer, 9, 108, 10.1186/1471-2407-9-108
Y Hai, 2020, Extended Prophylactic Antibiotics for Mastectomy with Immediate Breast Reconstruction: A Meta-analysis, Plast Reconstr Surg Glob Open, 8, e2613, 10.1097/GOX.0000000000002613
F Yamin, 2021, Routine Postoperative Antibiotics After Tissue Expander Placement Postmastectomy Does Not Improve Outcome, Ann Plast Surg, 87, S28, 10.1097/SAP.0000000000002826
J Masià, 2020, The largest multicentre data collection on prepectoral breast reconstruction: The iBAG study, J Surg Oncol, 122, 848, 10.1002/jso.26073
M Thill, 2020, Patient reported outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP(R) Bra): A prospective clinical study in 269 patients, Eur J Surg Oncol, 46, 1484, 10.1016/j.ejso.2020.04.009
I J Saldanha, 2021, Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis [Internet], 10.23970/AHRQEPCCER245
N Ganesh Kumar, 2021, Development of an evidence-based approach to the use of acellular dermal matrix in immediate expander-implant-based breast reconstruction, J Plast Reconstr Aesthet Surg, 74, 30, 10.1016/j.bjps.2020.10.005
M S Cabalag, 2016, Alloplastic adjuncts in breast reconstruction, Gland Surg, 5, 158
X Liu, 2015, Comparison of the postoperative incidence rate of capsular contracture among different breast implants: a cumulative meta-analysis, PLoS One, 10, e0116071, 10.1371/journal.pone.0116071
H Hallberg, 2018, Benefits and risks with acellular dermal matrix (ADM) and mesh support in immediate breast reconstruction: a systematic review and meta-analysis, J Plast Surg Hand Surg, 52, 130, 10.1080/2000656X.2017.1419141
O A Samargandi, 2018, Antibiotic Irrigation of Pocket for Implant-Based Breast Augmentation to Prevent Capsular Contracture: A Systematic Review, Plast Surg (Oakv), 26, 110, 10.1177/2292550317747854
Y Wang, 2020, Suppressive Effect of Leukotriene Antagonists on Capsular Contracture in Patients Who Underwent Breast Surgery with Prosthesis: A Meta-Analysis, Plast Reconstr Surg, 145, 901, 10.1097/PRS.0000000000006629
A Sood, 2017, Breast Massage, Implant Displacement, and Prevention of Capsular Contracture After Breast Augmentation With Implants: A Review of the Literature, Eplasty, 17, e41
M Friedrich, 2021, AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update, Geburtshilfe Frauenheilkd, 81, 1112, 10.1055/a-1499-8431
G F Schwartz, 2002, Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19–22, 2001, Philadelphia, PA, USA, Breast J, 8, 124, 10.1046/j.1524-4741.2002.08315.x
G H Lyman, 2014, Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update, J Clin Oncol, 32, 1365, 10.1200/JCO.2013.54.1177
C Elfgen, 2020, Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patientʼs perspective, Breast Cancer, 27, 1107, 10.1007/s12282-020-01114-y
R Rao, 2013, Axillary node interventions in breast cancer: a systematic review, JAMA, 310, 1385, 10.1001/jama.2013.277804
M Brackstone, 2021, Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline, J Clin Oncol, 39, 3056, 10.1200/JCO.21.00934
T A Moo, 2019, Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI, Ann Surg Oncol, 26, 4238, 10.1245/s10434-019-07867-x
B Gerber, 2022, Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial, Cancers (Basel), 14, 521, 10.3390/cancers14030521
A U Barron, 2018, Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy, JAMA Surg, 153, 1120, 10.1001/jamasurg.2018.2696
A B Tadros, 2017, Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery, JAMA Surg, 152, 665, 10.1001/jamasurg.2017.0562
J Heil, 2022, Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03, Ann Surg, 275, 576, 10.1097/SLA.0000000000004246
A Pfob, 2022, Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery, J Clin Oncol, 40, 1903, 10.1200/jco.21.02439
M Banys-Paluchowski, 2021, Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study, Cancers (Basel), 13, 1565, 10.3390/cancers13071565
L Schwentner, 2017, Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy – Results from the multi-center SENTINA trial, Breast, 31, 202, 10.1016/j.breast.2016.11.012
M Banys-Paluchowski, 2020, Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature, Arch Gynecol Obstet, 301, 341, 10.1007/s00404-019-05428-x
G Kirkilesis, 2021, False Negativity of Targeted Axillary Dissection in Breast Cancer, Breast Care (Basel), 16, 532, 10.1159/000513037
A V Barrio, 2021, Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event, JAMA Oncol, 7, 1851, 10.1001/jamaoncol.2021.4394